Login / Signup

Low-dose or high-dose amoxicillin in vonoprazan-based dual therapy for Helicobacter pylori eradication? A systematic review and meta-analysis.

Kun-Ping JuQing-Zhou KongYue-Yue LiYan-Qing Li
Published in: Helicobacter (2024)
VLA therapy demonstrated comparable efficacy and safety to VHA therapy, along with regional differences. An appropriately extended treatment duration may be critical for therapeutic optimization of vonoprazan-amoxicillin treatment.
Keyphrases
  • helicobacter pylori
  • low dose
  • high dose
  • helicobacter pylori infection
  • combination therapy
  • stem cell transplantation
  • bone marrow